Reversal of Right Ventricular Steatosis in Pulmonary Hypertension

Status Withdrawn

Clinical Trial Summary

The goal of this study is to elucidate the relationship between myocardial right ventricular triglyceride content (steatosis) and right ventricular dysfunction in participants with pulmonary hypertension, and investigate reversibility of this phenotype with omega-3 fatty acid treatment.

Clinical Trial Description

The investigators propose to treat 30 participants that are identified as having elevated myocardial triglyceride content (defined as greater than 0.50%) on cardiac MRI with 4 grams of omega-3 fatty acids daily for six months with a primary end point of reducing right ventricular steatosis and a secondary endpoint of improving RV systolic function. The investigators hypothesize that right ventricular steatosis by cardiac MRI will be associated with the degree of right ventricular systolic function by cardiac MRI. In the subset of participants with elevated baseline steatosis who are treated with a lipoprotective strategy, the investigators hypothesize that six months of therapy with omega-3 fatty acids will reduce myocardial steatosis and improve right ventricular systolic function. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02966899
Study type	Interventional
Source	Providence VA Medical Center
Contact
Status	Withdrawn
Phase	N/A
Start date	November 2016
Completion date	July 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01568424` - CentriMag RVAS U.S. Post-approval Study Protocol	N/A
Completed	`NCT03438825` - PRediction of Early PostoperAtive Right vEntricular Failure in Mitral Valve Replacement/Repair Patients
Recruiting	`NCT05758194` - Mitigating Post-Op RV Dysfunction After LVAD Implantation	N/A
Not yet recruiting	`NCT06310018` - Augmented Ultrasound-Facilitated, Catheter-Directed Fibrinolysis for PE	N/A
Terminated	`NCT03988842` - Standard-dose Apixaban AFtEr Very Low-dose ThromboLYSis for Acute Intermediate-high Risk Acute Pulmonary Embolism	Phase 4
Enrolling by invitation	`NCT01163422` - Right Ventricular Resynchronization Therapy	N/A
Completed	`NCT05855148` - Right Ventricle Dysfunction in Patients Undergoing Lung Transplant
Completed	`NCT05480345` - Significance of Impedance Cardiography and Early Repolarization Pattern in ECG in Congestive Heart Failure	N/A
Not yet recruiting	`NCT03341208` - Quantitative Assessment of RV Strain Using cMRI Following Catheter Intervention on PE	N/A